Abstract:Glucocorticoids are widely used in the treatment of allergic and inflammatory diseases. Glucocorticoids have a widespread action on gene expression resulting in their pharmacological actions and also an array of adverse effects which limit their clinical use. It remains, however, to be studied which target gene effects are essential for the anti‐allergic activity of glucocorticoids. Mitogen‐activated protein kinase phosphatase‐1 (MKP‐1) inhibits proinflammatory signalling by suppressing the activity of mitogen activated protein kinase (MAP kinase) pathways. MKP‐1 is one of the anti‐inflammatory genes whose expression is enhanced by glucocorticoids. In the present study, we aimed to investigate the role of MKP‐1 in the therapeutic effects of the glucocorticoid dexamethasone in acute allergic reaction. The effects of dexamethasone were studied in wild‐type and MKP‐1 deficient mice. The mice were first sensitized to ovalbumin, and the allergic reaction was then induced by a subcutaneous ovalbumin injection in the hind paw. Inflammatory edema was quantified with plethysmometer and expression of inflammatory factors was measured by quantitative reverse transcription polymerase chain reaction (RT‐PCR). Dexamethasone reduced the ovalbumin‐induced paw edema at 1.5, 3 and 6 h time points in wild‐type mice by 70%, 95% and 89%, respectively. The effect was largely abolished in MKP‐1 deficient mice. Furthermore, dexamethasone significantly attenuated the expression of ovalbumin‐induced inflammatory factors cyclooxygenase‐2 (COX‐2); inducible nitric oxide synthase (iNOS); interleukins (IL) 1β, 6 and 13; C‐C motif chemokine 11 (CCL‐11); tumour necrosis factor (TNF) and thymic stromal lymphopoietin (TSLP) in wild‐type mice by more than 40%. In contrast, in MKP‐1 deficient mice dexamethasone had no effect or even enhanced the expression of these inflammatory factors. The results suggest that dexamethasone alleviates allergic inflammation through an MKP‐1‐dependent mechanism. The results also demonstrate MKP‐1 as an important conveyor of the favourable glucocorticoid effects in ovalbumin‐induced type I allergic reaction. Together with previous findings, the present study supports the concept of MKP‐1 enhancing compounds as potential novel anti‐inflammatory and anti‐allergic drugs.

Glucocorticoid Receptor Modulators CpdX and CpdX-D3 Exhibit the Same in Vivo Antiinflammatory Activities As Synthetic Glucocorticoids.

The Glucocorticoid Receptor Agonistic Modulators CpdX and CpdX-D3 Do Not Generate the Debilitating Effects of Synthetic Glucocorticoids

Channel Expansion in the Ligand-Binding Domain of the Glucocorticoid Receptor Contributes to the Activity of Highly Potent Glucocorticoid Analogues

Glucocorticoid receptor agonist compound K regulates Dectin-1-dependent inflammatory signaling through inhibition of reactive oxygen species

A plant‐derived glucocorticoid receptor modulator with potency to attenuate the side effects of glucocorticoid therapy

Identification of 20(R, S)-protopanaxadiol and 20(R, S)-protopanaxatriol for Potential Selective Modulation of Glucocorticoid Receptor.

Glucocorticoid-induced Tethered Transrepression Requires SUMOylation of GR and Formation of a SUMO-SMRT/NCoR1-HDAC3 Repressing Complex.

Protopanaxadiol Derivative: A Plant Origin of Novel Selective Glucocorticoid Receptor Modulator with Anti-inflammatory Effect

Discovery of novel non-steroidal selective glucocorticoid receptor modulators by structure- and IGN-based virtual screening, structural optimization, and biological evaluation

The autophagy receptor SQSTM1/p62 mediates anti-inflammatory actions of the selective NR3C1/glucocorticoid receptor modulator compound A (CpdA) in macrophages

Discovery of a novel nonsteroidal selective glucocorticoid receptor modulator by virtual screening and bioassays

Mutant glucocorticoid receptor binding elements on the interleukin-6 promoter regulate dexamethasone effects

Anti-inflammatory Actions of Caesalpinin M2 in Experimental Colitis As a Selective Glucocoricoid Receptor Modulator.

New Insights into the Anti-inflammatory Mechanisms of Glucocorticoids: An Emerging Role for Glucocorticoid-Receptor-Mediated Transactivation

A High-Throughput Chemical Screen Identifies Novel Inhibitors and Enhancers of Anti-Inflammatory Functions of the Glucocorticoid Receptor

Synthesis and Anti-Cancer Activity of the Novel Selective Glucocorticoid Receptor Agonists of the Phenylethanolamine Series

Anti-Inflammatory Effects of A Cyclosporine Receptor-Binding Compound, D-43787

Comparison of the Glucocorticoid Receptor Binding and Agonist Activities of Typical Glucocorticoids: Insights into Their Endocrine Disrupting Effects

Mutations of Glucocorticoid Receptor Differentially Affect AF2 Domain Activity in a Steroid-Selective Manner to Alter the Potency and Efficacy of Gene Induction and Repression.

The glucocorticoid dexamethasone alleviates allergic inflammation through a mitogen‐activated protein kinase phosphatase‐1‐dependent mechanism in mice

NPD-0414-2 and NPD-0414-24, Two Chemical Entities Designed as Aryl Hydrocarbon Receptor (AhR) Ligands, Inhibit Gut Inflammatory Signals